Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras
Open Access
- 12 December 2000
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (26) , 14329-14333
- https://doi.org/10.1073/pnas.250494697
Abstract
Histone deacetylase 4 (HDAC4) is a member of a family of enzymes that catalyze the removal of acetyl groups from core histones, resulting in a compact chromatin structure that is generally associated with repressed gene transcription. Protein phosphorylation has been implicated in the regulation of the corepressor activity of the deacetylase. Here we report that serine/threonine kinases are found in association with HDAC4 and phosphorylate HDAC4 in vitro, and HDAC4 is phosphorylated in cells. The extracellular signal-regulated kinases 1 and 2 (ERK1/2), also known as p44MAPK and p42MAPK, respectively, are two of the kinases associated with HDAC4. ERK1/2 are components of the Ras–mitogen-activated protein kinase (MAPK) signal transduction pathway. Activation of the Ras–MAPK pathway by expression of oncogenic Ras or constitutively active MAPK/ERK kinase 1 results in an increased percentage of cells (from ≈10% to ≈70%) that express HDAC4 in the nucleus in C2C12 myoblast cells. In cells transfected with oncogenic Ras, nuclear HDAC4 is associated with kinase activity. Our results provide evidence that protein kinase activity is present in a protein complex with HDAC4 and directly links the Ras–MAPK signal transduction pathway to a mechanism for chromatin remodeling (i.e., histone deacetylation).Keywords
This publication has 33 references indexed in Scilit:
- 14-3-3 Proteins: Structure, Function, and RegulationAnnual Review of Pharmacology and Toxicology, 2000
- The language of covalent histone modificationsNature, 2000
- Regulation of Nuclear Localization: A Key to a DoorAnnual Review of Cell and Developmental Biology, 1999
- HDAC4 deacetylase associates with and represses the MEF2 transcription factorThe EMBO Journal, 1999
- Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylaseOncogene, 1999
- A New Family of Human Histone Deacetylases Related toSaccharomyces cerevisiae HDA1pJournal of Biological Chemistry, 1999
- TRANSCRIPTIONAL CONTROL OF MUSCLE DEVELOPMENT BY MYOCYTE ENHANCER FACTOR-2 (MEF2) PROTEINSAnnual Review of Cell and Developmental Biology, 1998
- Increasing complexity of Ras signalingOncogene, 1998
- Mitogen-activated protein kinase pathwaysCurrent Opinion in Cell Biology, 1997
- Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1Cell, 1989